What's Trending

Your source for perspectives, case studies and resources on the trends shaping oncology and cardiology benefit management

  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols

    Read Press Release
  • Webinar: Oncology in the wake of COVID-19: The lasting impact on cancer care

    Webinar: Oncology in the wake of COVID-19: The lasting impact on cancer care

    Join us on June 9 for a webinar to explore the future of cancer care in a post COVID-19 world.

    Register Now
  • New Century Health Pathways Help Community Practice Reduce Drug Spending

    New Century Health Pathways Help Community Practice Reduce Drug Spending

    Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.

    Read External Article
  • Let's Go
  • The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

    Watch Video
  • COVID-19 Resources for Providers and Health Plans

    COVID-19 Resources for Providers and Health Plans

    A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

    Read Article
  • Creating a "Culture of Yes" in Prior Authorization

    Creating a "Culture of Yes" in Prior Authorization

    Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.

    Read Article
  • The Financial Burden of Breast Cancer

    The Financial Burden of Breast Cancer

    As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.

    Read Article
  • Partnership and Pathways Drive Success in the Oncology Care Model

    Partnership and Pathways Drive Success in the Oncology Care Model

    Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.

    Watch Video
  • Lower Patient Costs Doesn’t Have to Mean Lower Profits

    Lower Patient Costs Doesn’t Have to Mean Lower Profits

    As the pace of treatment innovation threatens the financial health of both patients and oncology practices, it’s time to redefine reimbursement models to care for both financial and physical outcomes.

    Read External Article
  • The Clinical Oversight and Scientific Rigor to Design Higher-Quality Cancer Care

    The Clinical Oversight and Scientific Rigor to Design Higher-Quality Cancer Care

    New Century Health’s clinical pathways are rigorously developed and maintained by company clinicians under the oversight of an independent Scientific Advisory Board. Take a glimpse inside the board.

    Watch Video
  • Four Ways to Adapt to New Oncology Value-Based Models

    Four Ways to Adapt to New Oncology Value-Based Models

    Our CMO Dr. Andrew Hertler is quoted extensively in this Managed Healthcare Executive roundup of strategies for driving value in cancer care.

    Read External Article
  • Four Ways to Drive High-Value Drug Utilization in Oncology

    Four Ways to Drive High-Value Drug Utilization in Oncology

    Oncology drug spending in the U.S. is on an unsustainable trajectory. Explore four paths to curb costs without compromising care.

    Watch Video
  • Let's Go
  • Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.

    Read Article
  • Oncology Care First: What Providers Need to Know About CMS’ Proposed Model for Value-Based Cancer Care

    Oncology Care First: What Providers Need to Know About CMS’ Proposed Model for Value-Based Cancer Care

    Learn how CMS aims to increase risk, cash flow and predictability for practices while reducing administrative burdens, through its next model for value-based oncology care.

    Read Article
  • Cancer Spending in Medicaid: From Unmanaged Problem to Untapped Opportunity

    Cancer Spending in Medicaid: From Unmanaged Problem to Untapped Opportunity

    As cancer drug prices soar and innovation continues at a dizzying pace, Medicaid plans need a new set of tools to rein in spending and ensure high quality care.

    Read Article
  • Five Ways Oncology Has Become More Personalized

    Five Ways Oncology Has Become More Personalized

    How do you deliver individualized cancer care from both a scientific and human perspective? Read Managed Care Executive for our CMO Dr. Andrew Hertler's thoughts.

    Read External Article
  • Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions

    Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions

    Dr. Hertler, CMO at New Century Health, shares his thoughts and perspectives on the future of CAR T-cell therapy and the recent CMS announcements.

    Read Article
  • Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.

    Read Article
  • Positioning Providers to Take on Risk1:37

    Positioning Providers to Take on Risk

    As the market moves toward value-based care, one physician describes how New Century Health gave his practice the confidence and support to succeed in an advanced alternative payment model.

    Watch Video
  • Oncology Care Model: Looking Ahead to OCM 2.0

    Oncology Care Model: Looking Ahead to OCM 2.0

    Ashley Ridlon shares her insights into ways CMS can build on the benefits and momentum of the OCM and improve the program to help providers succeed in this model.

    Listen to Podcast
  • loading
    Loading More...